ac investment research

Should I Buy NASDAQ:TTOO Stock? (7% Forecasted Return) | TTOO T2 Biosystems Stock Forecast



Likewise, we do not consider factoring programs under sources of liquidity. Unlike asset-based lending (ABL) facilities, factoring is more of a sales transaction and not a loan. In addition, these transactions tend to be very short term. For this reason, we would not consider them a committed source of future liquidity over a 12-month period.The various qualitative factors in the criteria help to identify strengths and weaknesses within a company's future liquidity position that numerical ratios might not fully capture. While there is no size bias in our liquidity assessment, generally, lower-rated entities might meet the quantitative requirements for strong or exceptional liquidity but fail to meet corresponding qualitative factors. We estimate TTOO T2 Biosystems stock forecast parameters by: Hartley Oscillator with Beta because we use the multipliers stemming from the Gaussian distribution (with a 50% add-on for fat tail events) to transform a VaR at a x-confidence level into a VaR at the chosen confidence level (7% Forecasted Return)

NASDAQ:TTOO Stock Forecast (Buy or Sell) as of 22 Jun 2022 for (n+3 month)

Stock: TTOO T2 Biosystems

Time series to forecast n: 22 Jun 2022 for (n+3 month)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %

Stock Forecast Criteria and Models for TTOO T2 Biosystems

  • Derivatives receivables represent more than 0.5% of total assets for entities reporting under U.S. GAAP.
  • The analysis also considers certain entity-specific factors that we believe can distinguish an individual obligor from its peers. These may include diversification of the obligor's products and services as well as risk concentrations, particularly for a financial institution. Obligor-specific factors also may include operational effectiveness, overall competitive position, strategy, governance, financial policies, risk management practices, and risk tolerance.
  • In jurisdictions where the regulators have expressed no view on a specific hybrid capital instrument, we will base our assessment on our view of the likely regulatory policy with respect to the instrument. For instruments that are included in regulatory capital, including those that are grandfathered by the regulators, we assess the hybrid instrument in line with the remainder of these criteria.
  • The instrument will be classified as having no equity content if there is material uncertainty regarding whether the issuer will 1) keep it (or its replacement) outstanding for a sufficiently long period and 2) use it to absorb losses or conserve cash when needed.
  • The general nature of these sovereign default stress tests is described in table 3. The criteria apply one of three sovereign default scenarios--scenario A, B, or C-- depending on our assessment of the currency regime of the country.
  • On the qualitative side, the analysis of business entities focuses on various factors, including: country risk, industry characteristics, and entity-specific factors. We intend for our analysis of the country risk factor to capture our assessment of the financial and operating environment that applies broadly to businesses in a particular country, including a country's physical, legal, and financial infrastructure. Historically, this assessment has often operated to constrain the ratings of business entities in countries that have high country risk.
  • DTAs arising from temporary differences:For all institutions, the treatment of DTAs arising from temporary differences depends on whether their amount exceeds 10% of intermediate ACE. In this calculation, we use DTAs net of DTLs when the regulator allows such netting.

Assumptions Underlying The Forecast Model for TTOO T2 Biosystems

When an issuer has a shared revolving credit facility with a captive finance entity, for purposes of calculating the issuer's liquidity sources, we net outstanding commercial paper at the captive from the revolver's borrowing availability. In these cases, we generally use an estimate of peak CP borrowings at the captive to avoid potentially overstating sources available to the issuer over a 12- to 24-month period.

Frequently Asked QuestionsQ: Is TTOO T2 Biosystems stock buy or sell?
A: Likewise, we do not consider factoring programs under sources of liquidity. Unlike asset-based lending (ABL) facilities, factoring is more of a sales transaction and not a loan. In addition, these transactions tend to be very short term. For this reason, we would not consider them a committed source of future liquidity over a 12-month period.
Q: Is TTOO T2 Biosystems stock expected to go up?
A: The various qualitative factors in the criteria help to identify strengths and weaknesses within a company's future liquidity position that numerical ratios might not fully capture. While there is no size bias in our liquidity assessment, generally, lower-rated entities might meet the quantitative requirements for strong or exceptional liquidity but fail to meet corresponding qualitative factors.
Q: What is the forecast for TTOO T2 Biosystems ?
A: When an issuer has a shared revolving credit facility with a captive finance entity, for purposes of calculating the issuer's liquidity sources, we net outstanding commercial paper at the captive from the revolver's borrowing availability. In these cases, we generally use an estimate of peak CP borrowings at the captive to avoid potentially overstating sources available to the issuer over a 12- to 24-month period.
Q: What is the consensus rating of TTOO T2 Biosystems ?
A: The consensus rating for TTOO T2 Biosystems is 82.
Q: What are the risks of investing TTOO T2 Biosystems ?
A: We use risk analysis for TTOO T2 Biosystems because we use the multipliers stemming from the Gaussian distribution (with a 50% add-on for fat tail events) to transform a VaR at a x-confidence level into a VaR at the chosen confidence level


TTOO T2 Biosystems
AC Investment Research

In our experiment, we focus on an approach known as Decision making using game theory. We apply principles from game theory to model the relationships between rating actions, news, market signals and decision making.

301 Massachusetts Avenue Cambridge, MA 02139 667-253-1000 pr@ademcetinkaya.com